相关实验视频

Updated: Jan 17, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

探索炎症生物标志物与健康成年人肥胖的人类测量指标之间的关系:一项案例对照研究

Dekra Ali El-Aghbary¹, Rashad Ali Thabet², Mohammed A W Almorish³

¹Department of Medical Microbiology and Immunology, Faculty of Medicine and Health Sciences, Sana'a University, Sana'a, Yemen.

Diabetes, metabolic syndrome and obesity : targets and therapy

|September 15, 2025

概括

肥胖个体显示炎症生物标志物升高,这表明肥胖和炎症之间存在联系. 这些标志物可以预测与肥胖相关的健康风险.

科学领域:

医学研究医学研究
公共卫生公共卫生
炎症和免疫学炎症和免疫学

背景情况:

肥胖是一个主要的公共卫生问题,与各种健康危害有关.
炎症越来越被认为是肥胖相关代谢异常的一个关键因素.
炎症生物标志物是这些代谢障碍的关键指标.

研究的目的:

调查炎症生物标志物与肥胖的人类测量指标之间的相关性.
为了比较肥胖与非肥胖的健康成年人的炎症标志物.

主要方法:

病例控制研究设计,包括肥胖和不肥胖的健康成年人.
对人类测量指标的评估和采集血液样本.
测量完整血清 (CBC),C反应蛋白 (CRP),红细胞沉积率 (ESR) 和计算各种与炎症相关的比率 (NLR,PLR,MLR,SII).

主要成果:

与非肥胖个体相比,肥胖个体的总白细胞 (TWBC),中性粒细胞,单细胞,血小板,NLR,PLR,MLR和SII水平较高.
两组之间观察到ESR和CRP的显著差异.
ESR和CRP与BMI和体脂百分比呈正相关性,而淋巴细胞与肥胖指标呈混合相关性.

结论:

肥胖个体的血液生物标志物显著增加,表明肥胖和炎症之间存在强烈联系.
特定的炎症标志物可以作为肥胖相关健康风险的潜在预测因素.
需要进一步的研究来探索这些标记物的预测价值.

关键词:

这就是为什么BMI是BMI.在C-反应性蛋白质中.在PLR PLR中,人类测量指标是人类测量指标.红细胞沉率是什么炎症标志物炎症标志物肥胖肥胖肥胖肥胖肥胖肥胖肥胖肥胖

更多相关视频

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies

Published on: May 6, 2022

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

相关概念视频

Obesity

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...